Authors
Loading...
Research demonstrates that ligand interactions affect human serum albumin's binding to β-amyloid, implying new avenues for Alzheimer's disease therapies.
Shevelyova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: